Administration of Direct Oral Anticoagulants in Patients With Myeloproliferative Neoplasms

In this study, the authors analyzed the efficacy and safety of direct oral anticoagulants in patients treated for myeloproliferative neoplasms. Results did not show a significant difference in thrombotic or hemorrhagic events in patients treated with low-dose aspirin or direct oral anticoagulants. 

 Int J Hematol

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.